Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma

被引：72
作者：
Lemieux, B [1 ]
Tartas, S [1 ]
Traulle, C [1 ]
Espinouse, D [1 ]
Thieblemont, C [1 ]
Bouafia, F [1 ]
Alhusein, Q [1 ]
Antal, D [1 ]
Salles, G [1 ]
Coiffier, B [1 ]
机构：
[1] Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Haematol, F-69495 Pierre Benite, France
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷 / 09期
关键词：
non-Hodgkin's lymphoma; rituximab; autologous transplantation;
D O I：
10.1038/sj.bmt.1704467
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Rituximab, an anti-CD20 monoclonal antibody, is increasingly used in the treatment of B-cell non-Hodgkin's lymphoma. Late-onset neutropenia in relation to rituximab has been recently described. In this report, we present six cases occurring after stem cell transplantation and discuss the potential impact of this complication.
引用
收藏
页码：921 / 923
页数：3
相关论文
共 50 条
  • [31] Interstitial Pneumonia After Autologous Hematopoietic Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphoma
    Kato, Harumi
    Yamamoto, Kazuhito
    Taji, Hirofumi
    Oki, Yasuhiro
    Chihara, Dai
    Seto, Masao
    Kagami, Yoshitoyo
    Morishima, Yasuo
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06) : 483 - 489
  • [32] Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma
    J Shortt
    A Spencer
    [J]. Bone Marrow Transplantation, 2006, 38 : 433 - 436
  • [33] Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma
    Shortt, J.
    Spencer, A.
    [J]. BONE MARROW TRANSPLANTATION, 2006, 38 (06) : 433 - 436
  • [34] A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission on outcome
    Fanin, R
    Sperotto, A
    De Elvira, CR
    Zaja, F
    Stocchi, R
    Geromin, A
    Cerno, M
    Patriarca, F
    Canelles, MF
    Damiani, D
    Baccarani, M
    [J]. HAEMATOLOGICA, 2000, 85 (09) : 943 - 951
  • [35] Evans' syndrome following autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma
    Kamezaki, K
    Fukuda, T
    Makino, S
    Harada, M
    [J]. CLINICAL AND LABORATORY HAEMATOLOGY, 2004, 26 (04): : 291 - 293
  • [36] Plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation
    Moreb, Jan S.
    [J]. ONCOLOGY REVIEWS, 2011, 5 (01) : 67 - 73
  • [37] Allogeneic haemopoietic stem cell transplantation for non-Hodgkin's lymphoma
    Toze, CL
    Barnett, MJ
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (03) : 481 - 504
  • [38] Autologous peripheral blood stem cell transplantation in children and adolescents with non-Hodgkin lymphoma
    Gui, Wei
    Su, Liping
    He, Jianxia
    Wang, Lieyang
    Guan, Tao
    [J]. ONCOLOGY LETTERS, 2015, 10 (03) : 1826 - 1830
  • [39] Reconstitution of the cellular immune response after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin's lymphoma
    Nolte, A
    Buhmann, R
    Emmerich, B
    Schendel, D
    Hallek, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (02) : 415 - 423
  • [40] Crescentic glomerulonephritis developing 3 months after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma
    Takeuchi, M
    Tamaoki, A
    Tada, A
    Jyo, Y
    Nomura, S
    Takahashi, K
    Ohsawa, G
    Kibata, M
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 (07) : 725 - 727
12345